Trials / Completed
CompletedNCT02713581
IgG Dependent Monocyte Activation in Proximal Venous Thromboembolism
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 34 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to search for, in vitro, elements associated with IgG-dependent monocyte activation (signaling pathway activation, expression of pro-coagulant and pro-inflammatory factors) and to describe their prevalence in female patients with a history of proximal venous thromboembolism (proximal deep vein thrombosis or pulmonary embolism) compared to control women.
Detailed description
The secondary objectives of this study include to compare the IgG-dependent monocyte activation profiles as a function of laboratory thrombophilia parameters. Essentially: Is IgG-dependent cell activation associated with the presence of anti-phospholipid antibodies (or their subtypes?), or do these profiles indicate something beyond the nosology of anti-phospholipid syndrome?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood sampling | Venous blood will be sampled for laboratory analyses (see outcomes). |
Timeline
- Start date
- 2017-01-03
- Primary completion
- 2019-01-03
- Completion
- 2020-06-23
- First posted
- 2016-03-18
- Last updated
- 2020-06-30
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02713581. Inclusion in this directory is not an endorsement.